Atsena Therapeutics initiated part B of the phase 1/2 LIGHTHOUSE study investigating ATSN-201 for the treatment of X-linked retinoschisis, according to a press release.
If you continue to have this issue please contact [email protected]. Back to Healio The top retina articles on Healio this year included updates on pegcetacoplan in Europe, encapsulated ...
JAMA Ophthalmology (formerly Archives of Ophthalmology) is a monthly professional medical journal published by the American Medical Association. Archives of Ophthalmology publishes peer-reviewed ...
The NYU Grossman School of Medicine Department of Ophthalmology and Ophthalmology Times will host visiting faculty members from all ophthalmologic disciplines and a variety of academic departments in ...
Dr Heinrich Heimann, Augenklinik, University Hospital Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germanyheimann{at}ukbf.fu-berlin.de BACKGROUND Vasoproliferative tumours of the retina (VPTR ...
Although the first generation of OCT systems heralded a new era in the non-invasive diagnostic options in ophthalmology, they did not reveal much detail. Later devices offered more information and ...